{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T20:26:55Z","timestamp":1781987215873,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,19]]},"abstract":"<jats:p>To analyze the factors associated with the overall patient condition and explore the clinical value of the Patient Global Assessment (PGA) index for assessing the disease state in patients with Ankylosing Spondylitis (AS). This cross-sectional study used a standardized questionnaire to record the basic information of patients with AS. The collected data included the Ankylosing Spondylitis Disease Activity Score (ASDAS)-C-reactive protein (CRP), ASDAS-erythrocyte sedimentation rate (ESR), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), PGA, and other clinical indicators. Statistical analysis was performed using SPSS 25.0 software, and the scale was assessed for retest reliability and structural validity. The Kruskal\u2013Wallis H test and Spearman or Pearson correlation analysis were used to analyze the factors influencing PGA scores. The receiver operator characteristic (ROC) curve was used to identify the cutoff value of the PGA for predicting disease activity in AS. The patient age, disease duration, family history, and history of ocular inflammation significantly differed between PGA groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). The median PGA was significantly lower in patients with disease remission than in those with disease activity (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01). The various clinical indexes significantly differed between PGA groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01). The PGA was significantly correlated with various clinical indicators (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01). The area under the ROC curve (AUC) for disease activity based on the ASDAS-CRP was 0.743 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01) with a PGA cutoff value of 1.38; the AUC for disease activity based on the BASDAI was 0.715 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01) with a PGA cutoff value of 1.63. The PGA was significantly correlated with patient-reported outcomes, disease activity, function, and psychological status, and may indicate the level of inflammation in patients with AS. A PGA of around 1.5 indicates disease activity.<\/jats:p>","DOI":"10.1097\/md.0000000000037791","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T18:08:13Z","timestamp":1713550093000},"page":"e37791","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Clinical value of the Patient Global Assessment with Ankylosing Spondylitis: A cross-sectional study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-3023","authenticated-orcid":false,"given":"Yi-Fan","family":"Gong","sequence":"first","affiliation":[{"name":"Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Yang","family":"Geng","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[{"name":"Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yan","family":"Yan","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ying","family":"Zhen","sequence":"additional","affiliation":[{"name":"Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5455-0055","authenticated-orcid":false,"given":"Hong-Xiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis.","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R2-20250503","first-page":"893","article-title":"Diagnosis and treatment standards for ankylosing spondylitis.","volume":"61","author":"Huang","year":"2022","journal-title":"Chin J Intern Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states.","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","article-title":"Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives.","volume":"44","author":"Spoorenberg","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"R6-20250503","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R7-20250503","first-page":"732","article-title":"Significance of overall patient evaluation in assessing disease activity in patients with axial spinal arthritis.","volume":"21","author":"Wang","year":"2017","journal-title":"Chin J Rheumatol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/02729890122062622","article-title":"Visual analog scales: do they have a role in the measurement of preferences for health states?","volume":"21","author":"Torrance","year":"2001","journal-title":"Med Decis Making"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3899\/jrheum.200586","article-title":"The ASAS health index: a new era for health impact assessment in spondyloarthritis.","volume":"49","author":"Alonso","year":"2022","journal-title":"J Rheumatol"},{"key":"R11-20250503","first-page":"811","article-title":"Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis.","volume":"32","author":"Cella","year":"2005","journal-title":"J Rheumatol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jbspin.2016.11.013","article-title":"Patient and physician agreement on reported Bath Ankylosing Spondylitis Disease Activity Index in patients with axial spondyloarthritis.","volume":"84","author":"Ghukasyan","year":"2017","journal-title":"Joint Bone Spine"},{"key":"R15-20250503","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"R16-20250503","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index.","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J Rheumatol"},{"issue":"Pt 2","key":"R17-20250503","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1348\/014466505X29657","article-title":"The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample.","volume":"44","author":"Henry","year":"2005","journal-title":"Br J Clin Psychol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrrheum.2013.93","article-title":"Spondyloarthritis: is it time to replace BASDAI with ASDAS?","volume":"9","author":"Machado","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2020-219585","article-title":"Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial.","volume":"80","author":"Molto","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.847460","article-title":"The need for a new medical model: a challenge for biomedicine.","volume":"196","author":"Engel","year":"1977","journal-title":"Science"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/rheumatology\/kep287","article-title":"Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis.","volume":"48","author":"Minnock","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/ard.2007.069690","article-title":"Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis.","volume":"67","author":"Wells","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrrheum.2015.116","article-title":"Patient-reported outcomes in core domain sets for rheumatic diseases.","volume":"11","author":"van Tuyl","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.20790","article-title":"Assessment in Ankylosing Spondylitis International Working Group\/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis.","volume":"52","author":"van der Heijde","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis.","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:11:01Z","timestamp":1746317461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":25,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037791","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}